Sep 28, 2026 07:30AM
Aug 6, 2026 09:40AM
May 18, 2026 04:00PM
May 18, 2026 04:00PM
May 13, 2026 07:30AM
Feb 17, 2026 07:30AM
Nov 13, 2025 07:30AM Palatin Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Nov 12, 2025 12:15PM
Nov 12, 2025 12:15PM
Nov 6, 2025 08:00AM
Aug 8, 2025 04:00PM
Aug 8, 2025 04:00PM
May 14, 2025 07:30AM
May 9, 2025 07:30AM Internet Patents (PTNT) vPresents Promising Preclinical Data on Melanocortin Agonists for Retinopathy
May 9, 2025 07:30AM
May 8, 2025 10:19PM
May 8, 2025 04:39PM
May 7, 2025 08:01AM
May 7, 2025 08:00AM
May 5, 2025 07:30AM
Apr 29, 2025 07:30AM Palatin Technologies (PTN) Announces Breakthrough Symptom Resolution in Updated Analyses from Phase 3 PL9643 MELODY-1 Clinical Trial in Dry Eye Disease
Apr 29, 2025 07:30AM
Apr 17, 2025 07:30AM
Apr 17, 2025 07:30AM
Apr 10, 2025 07:30AM
Apr 10, 2025 07:30AM
Mar 31, 2025 07:36AM
Mar 31, 2025 07:30AM Palatin Announces MC4R Agonist Bremelanotide Co-Administered with GLP-1/GIP Tirzepatide Meets Primary Endpoint in Phase 2 Obesity Study
Mar 28, 2025 07:30AM
Mar 28, 2025 07:30AM
Mar 25, 2025 07:31AM
Mar 25, 2025 07:30AM
Feb 13, 2025 07:30AM
Feb 7, 2025 08:00AM
Feb 7, 2025 08:00AM Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement
Feb 6, 2025 07:32AM
Feb 6, 2025 07:30AM
Jan 28, 2025 07:31AM
Jan 28, 2025 07:30AM
Dec 19, 2024 07:31AM
Dec 19, 2024 07:30AM
Dec 16, 2024 07:31AM Palatin Technologies (PTN) Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds
Dec 16, 2024 07:30AM
Nov 25, 2024 07:30AM
Nov 14, 2024 07:30AM
Nov 4, 2024 07:30AM
Oct 31, 2024 07:30AM
Oct 24, 2024 07:30AM
Oct 23, 2024 07:30AM Palatin Presents Foundational Data on Novel and Highly Selective Melanocortin 4 Receptor Agonists at the 19th Annual Peptide Therapeutics Symposium
Oct 1, 2024 07:32AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All